Moreover, it can affect the expression of SREBP‐1 in the nucleus through the PI3K/AKT/mTOR pathway, and consequently influence the expression of downstream lipogenesis genes such as SCD1 and ACC, thus achieving the purpose of treating hyperlipidemia. This evidence concerns the gene AKT1 and hyperlipidemia.